Dexamethasone sodium phosphate
- Level
- Commodity
- Parent
- 51422300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51422342This classification denotes a therapeutic glucocorticoid with the molecular formula C22H28FO8P.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AI9376Y64P, chemically known as 16-alpha-methyl-9-alpha-fluoro-1,4-pregnadiene-11-beta,17-alpha,21-triol-3,20-dione but more generally known as dexamethasone sodium phosphate, which bears US NIH Compound Identifier 5743. European Medicines Agency schedules Dexamethasone sodium phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01615MIG. Most nations, for tariff and trade purposes, schedule dexamethasone sodium phosphate under HS 29372200 and SITC 54153. As of Q4 2014, DEXAMETHASONE SODIUM PHOSPHATE remains US FDA's Preferred Term for this commodity. Dexamethasone sodium phosphate bears US NLM identifiers UMLS ID C0113286 and NCI Concept Code C1362. SMILES: C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[NA+].[NA+].
Same parent
Under 51422300 · 70Activities that produce or sell this
KBLI · 9Inherited from family 51420000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.